Navigation Links
Cephalon Announces Strong Third Quarter Financial Results
Date:11/8/2007

Other current assets 34,626 47,278

Total current assets 1,365,996 1,108,804

PROPERTY AND EQUIPMENT, net 481,508 453,010

GOODWILL 476,605 467,167

INTANGIBLE ASSETS, net 839,255 793,037

DEFERRED TAX ASSETS, net 103,284 118,192

OTHER ASSETS 132,056 105,287

$3,398,704 $3,045,497

CURRENT LIABILITIES:

Current portion of long-term debt $1,237,285 $1,023,312

Accounts payable 74,528 90,586

Accrued expenses 685,864 263,478

Total current liabilities 1,997,677 1,377,376

LONG-TERM DEBT 4,373 224,992

DEFERRED TAX LIABILITIES, net 66,864 72,491

OTHER LIABILITIES 103,982 61,178

Total liabilities 2,172,896 1,736,037

STOCKHOLDERS' EQUITY:

Common stock, $0.01 par value 693 678

Additional paid-in capital 1,899,761 1,780,749

Treasury stock, at cost (151,196) (151,068)

Accumulated deficit (668,310) (425,256)

Accumulated other comprehensive income 144,860 104,357

Total stockholders' equity 1,225,808 1,309,460

$3,398,704 $3,045,497

Certain reclassifications of prior year amounts have been made to conform to the current year presentation. The NUVIGIL(R) (armodafinil) [C-IV] i
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
3. Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
4. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
5. Cephalon Quarterly Conference Call Invitation
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
8. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
9. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
10. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
11. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 2014  Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), ... proprietary technologies are used to discover, develop, manufacture ... bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, ... as Vice President and Chief Financial Officer. Tom ... information technology operations for Dyadic and will succeed ...
(Date:7/30/2014)... July 30, 2014   Epic Sciences, Inc. ... novel diagnostics to personalize and advance the treatment and ... Gregory T. Lucier as chairman of Epic,s board ... of Life Technologies (formerly Invitrogen). Mr. Lucier joins Epic,s ... its circulating rare cell analysis platform with special focus ...
(Date:7/30/2014)... , July 30, 2014  RXi Pharmaceuticals ... biotechnology company focused on discovering, developing and ... needs using RNA-targeted technologies, today announced that ... RXI-109, for the reduction of recurrence of ... has been initiated. Logo - ...
(Date:7/30/2014)... July 30, 2014 Connecticut Center for ... based in East Hartford, Conn., was awarded a Rural ... of a project that will determine the feasibility of ... north-central Connecticut. USDA Rural Development provided $53,000 for CCAT ... the second phase of the feasibility study in fiscal ...
Breaking Biology Technology:Thomas Dubinski joins Dyadic as Chief Financial Officer 2Thomas Dubinski joins Dyadic as Chief Financial Officer 3Thomas Dubinski joins Dyadic as Chief Financial Officer 4Epic Sciences Appoints Greg Lucier as Chairman of the Board of Directors 2Epic Sciences Appoints Greg Lucier as Chairman of the Board of Directors 3RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 2RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 3RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 4RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 5USDA Grant Funds Second Phase of Bio-Energy Research Community Economic Development in CT 2USDA Grant Funds Second Phase of Bio-Energy Research Community Economic Development in CT 3
... 11 Lucid, Inc., (http://www.lucid-tech.com ), a leading ... Colin Stahel as Director, Asia Pacific Region., ... the newly created,position based on his extensive medical ... experience in the development of medical,technology and pre-cancer ...
... Belgium, December 11 , - TB-402 Shows ... Prevention of Thromboembolic Disorders., ThromboGenics NV (Euronext ... disease, announced that the results of the,first Phase ... the prestigious,American Society of Hematology (ASH) 49th Annual ...
... Mass., Dec. 10 Cambridge Research &,Instrumentation, Inc. ... breakthrough system that converts any brightfield or,fluorescent microscope ... of a larger specimens, such as embryos,zebrafish, plants, ... can,be mounted onto a fluorescent macroscope. The Nuance ...
Cached Biology Technology:Lucid Expands Support Internationally: Dr. Colin Stahel appointed Director for Asia Pacific Region 2ThromboGenics Presents Results of the Phase I Trial of TB-402 at the Prestigious American Society of Hematology Annual Meeting 2ThromboGenics Presents Results of the Phase I Trial of TB-402 at the Prestigious American Society of Hematology Annual Meeting 3ThromboGenics Presents Results of the Phase I Trial of TB-402 at the Prestigious American Society of Hematology Annual Meeting 4CRi Announces Nuance 2, the Next-Generation Multispectral Imaging System for Brightfield and Fluorescent-Based Microscopy 2
(Date:7/30/2014)... Scientists are searching through a massive collection of ... 50 years ago, and the effort is yielding fresh ... inhabited. , When the collection is fully curated, a ... the largest unbiased Dominican amber collection in the world, ... discovery thus far is that of a pygmy locust, ...
(Date:7/30/2014)... Wayne State University,s College of Engineering recently received ... for the project, "Nanoparticle-directed synthesis of organic nanorods." ... nanotechnology is the creation and utilization of functional ... functions. A major bottleneck in scaling up nanotechnology ... different functional materials into one device. A research ...
(Date:7/30/2014)... major interest in neuroscience. A large number of ... of Wallerian degeneration: transcription factor activation, immune response, ... responses in the distal segment of the sciatic ... in gene expression between the proximal and distal ... from Nantong University, China used microarrays to analyze ...
Breaking Biology News(10 mins):Decades-old amber collection offers new views of a lost world 2NSF grant to Wayne State supports new concept for manufacturing nanoscale devices 2
... 10, 2010) -- Just as the path of photons of ... magnetic moment can be controlled using a magnetic mirror. Research ... the feasibility of using magnetic domain walls to direct and ... "We are looking for ways to build magnetic ...
... , This release is available in Spanish ... were found to have low serum (blood) zinc concentrations during ... and the National Institute of Aging. The scientists ... 50 percent less likely to develop pneumonia than those with ...
... - A new technology enabling tiny machines called ... super-accurate and precise sensors for crime-scene forensics, environmental ... enable researchers to create a "nose-on-a-chip" for tracking ... gaseous substances, as well as a new class ...
Cached Biology News:Adequate zinc eases pneumonia in elderly 2Innovation could bring super-accurate sensors, crime forensics 2Innovation could bring super-accurate sensors, crime forensics 3Innovation could bring super-accurate sensors, crime forensics 4
...
Recalibration of HL-2000-CAL products...
Mature rat whole blood (Sprague-Dawley, averaging 7-8 weeks of age, either sex) is collected at the time of slaughter and processed within 45 minutes. It is then filtered through gauze, pooled in an ...
Several Pichia pastoris strains are available to allow you to optimize expression and recovery of your protein of interest. Table 1 provides information to help you choose the appropriate strain....
Biology Products: